Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems serology for evaluation of HIV vaccine trials
Margaret E. Ackerman, Dan H. Barouch, Galit Alter
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 262-270
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Control of Heterologous Simian Immunodeficiency Virus SIV smE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
Shakti Singh, Eric G. Ramírez-Salazar, Rami Doueiri, et al.
Journal of Virology (2018) Vol. 92, Iss. 15
Open Access | Times Cited: 36
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity
Claus Kadelka, Thomas Liechti, Hanna Ebner, et al.
The Journal of Experimental Medicine (2018) Vol. 215, Iss. 6, pp. 1589-1608
Open Access | Times Cited: 34
Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation
Elisabeth A. van Erp, Anke J. Lakerveld, Erik de Graaf, et al.
Clinical & Translational Immunology (2020) Vol. 9, Iss. 2
Open Access | Times Cited: 30
High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination
Adam S. Dingens, Payal Pratap, Keara D. Malone, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 25
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes
Ofer Zimmerman, Alexa Michelle Altman Doss, Paulina Kapłonek, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 6, pp. 100653-100653
Open Access | Times Cited: 15
Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans
Lue Ping Zhao, Andrew Fioré-Gartland, Lindsay N. Carpp, et al.
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0226803-e0226803
Open Access | Times Cited: 23
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Anti-HIV-1 antibody-dependent cellular cytotoxicity
Wen Shi Lee, Stephen J. Kent
Current Opinion in HIV and AIDS (2017) Vol. 13, Iss. 2, pp. 160-166
Closed Access | Times Cited: 23
Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
Jing Cai, Bo‐Dou Zhang, Yuqi Li, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1290-1290
Open Access | Times Cited: 17
Problems With Understanding Chlamydia trachomatis Immunology
Robert C. Brunham
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 11, pp. 2043-2049
Closed Access | Times Cited: 16
Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection
Srivamshi Pittala, Kenneth Bagley, Jennifer A. Schwartz, et al.
Molecular Systems Biology (2019) Vol. 15, Iss. 5
Open Access | Times Cited: 19
Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types
Martin Ryser, Valérie Berlaimont, Naveen Karkada, et al.
Expert Review of Vaccines (2019) Vol. 18, Iss. 3, pp. 309-322
Closed Access | Times Cited: 18
Systems Biological Analysis of Immune Response to Influenza Vaccination
Mario Cortese, Amy C Sherman, Nadine Rouphael, et al.
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 6, pp. a038596-a038596
Open Access | Times Cited: 17
Expression Profiling and Glycan Engineering of IgG Subclass 1–4 in Nicotiana benthamiana
Somanath Kallolimath, Thomas Hackl, Raphaela Gahn, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 17
IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees
Stephanie Fischinger, Sepideh Dolatshahi, Madeleine F. Jennewein, et al.
JCI Insight (2020) Vol. 5, Iss. 21
Open Access | Times Cited: 17
Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines
Yixiang Deng, Caroline Atyeo, Dansu Yuan, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113292-113292
Open Access | Times Cited: 5
First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines
Francesco Borriello, Simon D. van Haren, Ofer Levy
mSphere (2018) Vol. 3, Iss. 4
Open Access | Times Cited: 18
A flow cytometry‐based assay to determine the phagocytic activity of both clinical and nonclinical antibody samples against Chlamydia trachomatis
Marco Grasse, Ida Rosenkrands, Anja Weinreich Olsen, et al.
Cytometry Part A (2018) Vol. 93, Iss. 5, pp. 525-532
Open Access | Times Cited: 17
The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection
Leah C. Katzelnick, Eva Harris
Current Opinion in Virology (2018) Vol. 29, pp. 51-61
Open Access | Times Cited: 16
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers
Ralf Duerr, Miroslaw K. Górny
Vaccines (2019) Vol. 7, Iss. 3, pp. 82-82
Open Access | Times Cited: 16
Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines
Svenja Weiß, Vincenza Itri, Ruimin Pan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 9
The applications of machine learning in HIV neutralizing antibodies research—A systematic review
Vlad-Rareş Dănăilă, Speranța Avram, Cătălin Buiu
Artificial Intelligence in Medicine (2022) Vol. 134, pp. 102429-102429
Open Access | Times Cited: 9
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice
James Brett Case, Shilpa Sanapala, Carly Dillen, et al.
Cell Host & Microbe (2024)
Open Access | Times Cited: 1
Development of a Macrophage-Based ADCC Assay
Melissa B. Uccellini, Sadaf Aslam, Sean Liu, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 660-660
Open Access | Times Cited: 12
Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis
Meredith Phelps, Alejandro B. Balazs
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 12

Scroll to top